Global Anticancer Drugs Competitive Landscape Professional Research Report 2024

Research Summary

Anticancer drugs are medications specifically designed to treat cancer by targeting and inhibiting the growth and spread of cancer cells. These drugs work through various mechanisms, including interfering with cell division, blocking the formation of blood vessels that tumors need to grow, promoting cancer cell death (apoptosis), or boosting the body's immune response against cancer cells. Anticancer drugs can be classified into several categories, including chemotherapy, targeted therapy, immunotherapy, hormone therapy, and anti-angiogenesis drugs, among others. Chemotherapy drugs, such as paclitaxel and cisplatin, work by killing rapidly dividing cells, including cancer cells, but can also affect healthy cells. Targeted therapy drugs, like imatinib and trastuzumab, specifically target molecules or pathways that are involved in the growth and survival of cancer cells, while sparing healthy cells. Immunotherapy drugs, such as checkpoint inhibitors and CAR-T cell therapy, help the immune system recognize and attack cancer cells. Hormone therapy drugs, like tamoxifen and leuprolide, block the effects of certain hormones that promote the growth of hormone-sensitive cancers. Anti-angiogenesis drugs, such as bevacizumab, inhibit the growth of new blood vessels that tumors need for their growth. Anticancer drugs are often used in combination or as part of a multidisciplinary approach to cancer treatment, which may also include surgery, radiation therapy, and other interventions. The choice of anticancer drugs and treatment regimen depends on factors such as the type and stage of cancer, the patient's overall health, and individualized treatment goals.

According to DIResearch's in-depth investigation and research, the global Anticancer Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Anticancer Drugs include AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Anticancer Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Anticancer Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Anticancer Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Anticancer Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Anticancer Drugs Include:

AbbVie

Johnson & Johnson

Novartis

Gilead Sciences

Roche

Bristol-Myers Squibb

Amgen

AstraZeneca

Merck & Co

Takeda

Merck KGaA

Seagen

Eli Lilly

Ono Pharmaceutical

Pfizer

GSK

Exelixis

Regeneron

Innovent

Hengrui Medicine

Anticancer Drugs Product Segment Include:

Cancer Immunotherapy

Targeted Therapy

Chemotherapy

Other

Anticancer Drugs Product Application Include:

Lung Cancer

Breast Cancer

Prostate Cancer

Blood-related Cancer

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Anticancer Drugs Industry PESTEL Analysis

Chapter 3: Global Anticancer Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Anticancer Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Anticancer Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Anticancer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Anticancer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Anticancer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Anticancer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Anticancer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Anticancer Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Anticancer Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Anticancer Drugs Market Overview

1.1 Product Definition and Statistical Scope

1.2 Anticancer Drugs Product by Type

1.2.1 Global Anticancer Drugs Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Cancer Immunotherapy

1.2.3 Targeted Therapy

1.2.4 Chemotherapy

1.2.5 Other

1.3 Anticancer Drugs Product by Application

1.3.1 Global Anticancer Drugs Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Prostate Cancer

1.3.5 Blood-related Cancer

1.3.6 Other

1.4 Global Anticancer Drugs Market Revenue Analysis (2019-2030)

1.5 Anticancer Drugs Market Development Status and Trends

1.5.1 Anticancer Drugs Industry Development Status Analysis

1.5.2 Anticancer Drugs Industry Development Trends Analysis

2 Anticancer Drugs Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Anticancer Drugs Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Anticancer Drugs Market Analysis by Regions

4.1 Anticancer Drugs Overall Market: 2023 VS 2024 VS 2030

4.2 Global Anticancer Drugs Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Anticancer Drugs Revenue and Market Share by Region (2019-2024)

4.2.2 Global Anticancer Drugs Revenue Forecast by Region (2025-2030)

5 Global Anticancer Drugs Market Size by Type and Application

5.1 Global Anticancer Drugs Market Size by Type

5.2 Global Anticancer Drugs Market Size by Application

6 North America

6.1 North America Anticancer Drugs Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Anticancer Drugs Market Size by Type

6.4 North America Anticancer Drugs Market Size by Application

6.5 North America Anticancer Drugs Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Anticancer Drugs Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Anticancer Drugs Market Size by Type

7.4 Europe Anticancer Drugs Market Size by Application

7.5 Europe Anticancer Drugs Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Anticancer Drugs Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Anticancer Drugs Market Size by Type

8.4 China Anticancer Drugs Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Anticancer Drugs Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Anticancer Drugs Market Size by Type

9.4 APAC (excl. China) Anticancer Drugs Market Size by Application

9.5 APAC (excl. China) Anticancer Drugs Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Anticancer Drugs Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Anticancer Drugs Market Size by Type

10.4 Latin America Anticancer Drugs Market Size by Application

10.5 Latin America Anticancer Drugs Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Anticancer Drugs Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Anticancer Drugs Market Size by Type

11.4 Middle East & Africa Anticancer Drugs Market Size by Application

11.5 Middle East & Africa Anticancer Drugs Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Anticancer Drugs Market Revenue by Key Manufacturers (2020-2024)

12.2 Anticancer Drugs Competitive Landscape Analysis and Market Dynamic

12.2.1 Anticancer Drugs Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 AbbVie

13.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 AbbVie Anticancer Drugs Product Portfolio

13.1.3 AbbVie Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Johnson & Johnson Anticancer Drugs Product Portfolio

13.2.3 Johnson & Johnson Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Novartis

13.3.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Novartis Anticancer Drugs Product Portfolio

13.3.3 Novartis Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Gilead Sciences

13.4.1 Gilead Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Gilead Sciences Anticancer Drugs Product Portfolio

13.4.3 Gilead Sciences Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Roche

13.5.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Roche Anticancer Drugs Product Portfolio

13.5.3 Roche Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Bristol-Myers Squibb

13.6.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Bristol-Myers Squibb Anticancer Drugs Product Portfolio

13.6.3 Bristol-Myers Squibb Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Amgen

13.7.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Amgen Anticancer Drugs Product Portfolio

13.7.3 Amgen Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 AstraZeneca

13.8.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 AstraZeneca Anticancer Drugs Product Portfolio

13.8.3 AstraZeneca Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Merck & Co

13.9.1 Merck & Co Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Merck & Co Anticancer Drugs Product Portfolio

13.9.3 Merck & Co Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Takeda

13.10.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Takeda Anticancer Drugs Product Portfolio

13.10.3 Takeda Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Merck KGaA

13.11.1 Merck KGaA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Merck KGaA Anticancer Drugs Product Portfolio

13.11.3 Merck KGaA Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Seagen

13.12.1 Seagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Seagen Anticancer Drugs Product Portfolio

13.12.3 Seagen Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Eli Lilly

13.13.1 Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Eli Lilly Anticancer Drugs Product Portfolio

13.13.3 Eli Lilly Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Ono Pharmaceutical

13.14.1 Ono Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Ono Pharmaceutical Anticancer Drugs Product Portfolio

13.14.3 Ono Pharmaceutical Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Pfizer

13.15.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Pfizer Anticancer Drugs Product Portfolio

13.15.3 Pfizer Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 GSK

13.16.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 GSK Anticancer Drugs Product Portfolio

13.16.3 GSK Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Exelixis

13.17.1 Exelixis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Exelixis Anticancer Drugs Product Portfolio

13.17.3 Exelixis Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Regeneron

13.18.1 Regeneron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Regeneron Anticancer Drugs Product Portfolio

13.18.3 Regeneron Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Innovent

13.19.1 Innovent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Innovent Anticancer Drugs Product Portfolio

13.19.3 Innovent Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Hengrui Medicine

13.20.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Hengrui Medicine Anticancer Drugs Product Portfolio

13.20.3 Hengrui Medicine Anticancer Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Anticancer Drugs Industry Chain Analysis

14.2 Anticancer Drugs Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Anticancer Drugs Typical Downstream Customers

14.4 Anticancer Drugs Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support